Glucocorticoid receptor agonist composed of 2,2,4-trimethyl-6-phenyl-1,2-dihydroqui noline derivatives having substituted oxy group

Details for Australian Patent Application No. 2009247250 (hide)

Owner SANTEN PHARMACEUTICAL CO., LTD.

Inventors Dota, Atsuyoshi; Kurose, Tatsuji; Kato, Masatomo; Hagiwara, Yumi; Takai, Miwa; Matsuda, Mamoru; Mori, Toshiyuki; Matsuyama, Takahiro; Imoto, Kenji

Agent Collison & Co

Pub. Number AU-A-2009247250

PCT Pub. Number WO2009/139361

Priority 2008-124714 12.05.08 JP

Filing date 12 May 2009

Wipo publication date 19 November 2009

International Classifications

C07D 215/14 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

A61K 31/47 (2006.01) - Quinolines

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/5377 (2006.01)

A61P 1/02 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 1/16 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/08 (2006.01) Drugs for disorders of the metabolism

A61P 5/14 (2006.01) Drugs for disorders of the endocrine system

A61P 5/16 (2006.01) Drugs for disorders of the endocrine system

A61P 5/38 (2006.01) Drugs for disorders of the endocrine system

A61P 5/44 (2006.01) Drugs for disorders of the endocrine system

A61P 7/00 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 7/04 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 7/06 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 11/02 (2006.01) Drugs for disorders of the respiratory system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

A61P 15/00 (2006.01) Drugs for genital or sexual disorders

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 17/02 (2006.01) Drugs for dermatological disorders

Event Publications

23 December 2010 Amendment Made

  The nature of the amendment is: Amend invention title to read Glucocorticoid receptor agonist composed of 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline derivatives having substituted oxy group

13 January 2011 PCT application entered the National Phase

  PCT publication WO2009/139361 Priority application(s): WO2009/139361

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009247251-Pharmaceutical preparation comprising DPP-IV inhibitor and other diabetes therapeutic agent in concomitant or combined form

2009247219-Centrifugal fan